The North America patient support technology market size is anticipated to reach USD 1.34 billion by 2030, expanding at a CAGR of 11.0% from 2023 to 2030. The increasing demand for comprehensive patient-centric engagement solutions in pharmaceutical firms, AI-enabled technologies, adoption of chatbots in Patient Support Programs (PSPs), and the enhanced adoption of patient support technology to improve medication adherence are the notable drivers contributing to overall market growth.
For instance, in a published case study, CONNECTED HEALTH highlighted its success in promoting patient engagement in diabetes education and medication refilling. The company integrated the HealthPrize adherence platform with a well-established Customer Relationship Management (CRM) program for a prominent injectable diabetes medication franchise. The study revealed a substantial increase in medication adherence, with an average of 2.9 additional prescription fills during the study period. This improved the brand's return on investment and also offered valuable insights into patient adherence behaviors and performance.
The market is divided into standalone and integrated type segments. In 2022, the integrated segment held the majority market share of over 65%. This dominance is attributed to technological advancements, demand for streamlined healthcare processes, and growing emphasis on patient-centered care. For instance, AllazoHealth's AI-powered Patient Support Program (PSP) has significantly enhanced medication adherence. In a published case study, patients participating in this program adhered 4.6 times longer than those without AI support.
Key market participants are actively implementing strategies such as mergers, acquisitions, partnerships, and product launches to broaden their global presence and product offerings. In July 2023, Inizio Engage introduced Patient Access Services, an extensive suite of patient support services tailored to enhance access to and comply adherence with specialty therapies. This initiative leverages the capabilities of the Trak360 platform, which integrates advanced features for seamless and secure patient engagement. These enhancements streamline the patients' treatment journeys, ensuring a fully integrated and cohesive experience from diagnosis to ongoing engagement and support.
This product will be delivered within 1-3 business days.
For instance, in a published case study, CONNECTED HEALTH highlighted its success in promoting patient engagement in diabetes education and medication refilling. The company integrated the HealthPrize adherence platform with a well-established Customer Relationship Management (CRM) program for a prominent injectable diabetes medication franchise. The study revealed a substantial increase in medication adherence, with an average of 2.9 additional prescription fills during the study period. This improved the brand's return on investment and also offered valuable insights into patient adherence behaviors and performance.
The market is divided into standalone and integrated type segments. In 2022, the integrated segment held the majority market share of over 65%. This dominance is attributed to technological advancements, demand for streamlined healthcare processes, and growing emphasis on patient-centered care. For instance, AllazoHealth's AI-powered Patient Support Program (PSP) has significantly enhanced medication adherence. In a published case study, patients participating in this program adhered 4.6 times longer than those without AI support.
Key market participants are actively implementing strategies such as mergers, acquisitions, partnerships, and product launches to broaden their global presence and product offerings. In July 2023, Inizio Engage introduced Patient Access Services, an extensive suite of patient support services tailored to enhance access to and comply adherence with specialty therapies. This initiative leverages the capabilities of the Trak360 platform, which integrates advanced features for seamless and secure patient engagement. These enhancements streamline the patients' treatment journeys, ensuring a fully integrated and cohesive experience from diagnosis to ongoing engagement and support.
North America Patient Support Technology Market Report Highlights
- Based on type, the market is segmented into standalone and integrated segments. The integrated segment held the dominant position in 2022 with a market share of over 65%. This growth is propelled by an increased emphasis on patient-centered care, technological advancements, and the demand for more streamlined and efficient healthcare processes
- Based on region, North America is witnessing a surge in demand for patient support technology, driven by the growing emphasis on patient-centered healthcare, ongoing digital transformation in the healthcare industry, and the transition from fee-for-service to value-based care models. In 2022, the U.S. dominated the North American market due to the increased presence of healthcare organizations seeking structured data and automation solutions
- Notable players in the market are consistently prioritizing product launches, partnerships, and geographical expansion strategies to maintain their market presence.
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. Market Variables, Trends, & Scope
Chapter 4. Type Business Analysis
Chapter 5. Country Business Analysis
Chapter 6. Competitive Landscape
List of Tables
List of Figures
Companies Mentioned
- Deloitte
- Accenture
- McKesson Corporation
- Cardinal Health
- Inizio Engage
- DataRiver S.r.l
- AssistRx
- Medisafe
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 195 |
| Published | September 2023 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value ( USD | $ 577.1 Million |
| Forecasted Market Value ( USD | $ 1340 Million |
| Compound Annual Growth Rate | 11.0% |
| Regions Covered | North America |
| No. of Companies Mentioned | 8 |
